Health Canada Recalls Blood Pressure Medication Due to Labeling Mix-Up
A recall has been issued for a blood pressure medication due to a labeling mix-up that may have serious health implications. Health Canada announced that Marcan Pharmaceuticals Inc. is recalling specific lots of MAR-Amlodipine tablets.
Details of the Recall
Two lots of MAR-Amlodipine 5 milligram tablets are affected. These tablets are typically prescribed for managing high blood pressure and alleviating chest pain. However, some bottles may mistakenly contain 2.5 milligram tablets of midodrine, a medication designed for treating low blood pressure.
Identification of the Medications
- MAR-Amlodipine 5 mg: White or off-white, flat, eight-sided tablets with the numbers 210 and 5 on one side and a score line in the middle.
- Midodrine 2.5 mg: White, round tablets marked with M2 on one side and having a score line on the other side.
Health Risks Associated with the Mix-Up
Health Canada warns that taking midodrine instead of amlodipine can cause serious side effects. Possible risks include:
- Dangerous increases in blood pressure
- Dizziness
- Fainting
- Organ damage
What to Do If You Are Affected
Patients who have received the incorrect medication should promptly return the affected bottles to their pharmacy for a replacement. Health Canada emphasizes that anyone experiencing symptoms such as dizziness, unusually high blood pressure, or slow heartbeats should seek professional medical assistance or dial 911.
Furthermore, individuals experiencing severe symptoms such as chest pain, sudden headaches, impaired speech, or any loss of sensation should seek immediate medical attention.
Always stay informed about your medications and consult healthcare professionals if unsure about your treatment plans. For more updates, visit Filmogaz.com.
